These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database. Sun Y; Miller DC; Akpandak I; Chen EM; Arnold BF; Acharya NR Ophthalmology; 2022 Oct; 129(10):1096-1106. PubMed ID: 35588945 [TBL] [Abstract][Full Text] [Related]
45. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047 [TBL] [Abstract][Full Text] [Related]
46. Treatment of noninfectious uveitis. Ferreira LB; Farrall AL; Furtado JM; Smith JR Arq Bras Oftalmol; 2021; 84(6):610-621. PubMed ID: 34431877 [TBL] [Abstract][Full Text] [Related]
47. Uveitis Therapy: The Corticosteroid Options. Valdes LM; Sobrin L Drugs; 2020 Jun; 80(8):765-773. PubMed ID: 32350761 [TBL] [Abstract][Full Text] [Related]
48. Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA). Nguyen QD; Merrill PT; Clark WL; Banker AS; Fardeau C; Franco P; LeHoang P; Ohno S; Rathinam SR; Thurau S; Abraham A; Wilson L; Yang Y; Shams N; Ophthalmology; 2016 Nov; 123(11):2413-2423. PubMed ID: 27692526 [TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies. Hiyama T; Harada Y; Kiuchi Y Ocul Immunol Inflamm; 2022 May; 30(4):951-958. PubMed ID: 33560160 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571 [TBL] [Abstract][Full Text] [Related]
52. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study. Rivas AB; Lopez-Picado A; Calamia V; Carreño E; Cocho L; Cordero-Coma M; Fonollosa A; Francisco Hernandez FM; Garcia-Aparicio A; Garcia-Gonzalez J; Mondejar JJ; Lojo-Oliveira L; Martínez-Costa L; Munoz S; Peiteado D; Pinto JA; Rodriguez-Lozano B; Pato E; Diaz-Valle D; Molina E; Tebar LA; Rodriguez-Rodriguez L; BMJ Open; 2022 Mar; 12(3):e051378. PubMed ID: 35318229 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of Adalimumab in Non-Infectious Uveitis Across Different Etiologies: A Post Hoc Analysis of the VISUAL I and VISUAL II Trials. Merrill PT; Vitale A; Zierhut M; Goto H; Kron M; Song AP; Pathai S; Fortin E Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1569-1575. PubMed ID: 32469621 [No Abstract] [Full Text] [Related]
54. Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy. Eurelings LEM; Missotten TOAR; van Velthoven MEJ; van Daele PLA; van Laar JAM; van Hagen PM; Thiadens AAHJ; Rombach SM Am J Ophthalmol; 2022 Aug; 240():194-204. PubMed ID: 35314190 [TBL] [Abstract][Full Text] [Related]